Syndax Pharmaceuticals, Inc.
SNDX
$10.99
$0.292.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.19% | -29.94% | -64.48% | -52.56% | -76.04% |
| Total Depreciation and Amortization | -- | -100.00% | -33.33% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.57% | 87.15% | 87.20% | 44.33% | 123.52% |
| Change in Net Operating Assets | -5.81% | 4.52% | 693.90% | -312.31% | -3,289.51% |
| Cash from Operations | -13.90% | -38.79% | -39.57% | -102.55% | -112.98% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 194.71% | -1,551.15% | 116.70% | -16.45% | -599.12% |
| Cash from Investing | 194.71% | -1,551.15% | 116.70% | -16.45% | -599.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -57.10% | -98.54% | 67.37% | -48.94% | -12.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -57.10% | 34.41% | 67.37% | -48.94% | -12.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.95% | -89.51% | 1,113.69% | -123.13% | -973.57% |